TOXICITY OF WEEKLY LIPOSOMAL DOXORUBICIN AND PACLITAXEL IN METASTATIC BREAST CANCER (MBC)

被引：0
|
作者：
Longo, F. [1 ]
Pellegrini, P. [1 ]
Ceccarelli, F. [1 ]
Borgomastro, A. [1 ]
Comito, T. [1 ]
Basile, M. L. [1 ]
De Biasio, G. [2 ]
Girolami, M. [2 ]
Spalletta, B. [1 ]
Di Seri, M. [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
[2] Univ Roma La Sapienza, Dept Surg 4, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [21] Salvage treatment in metastatic breast cancer (MBC) with weekly paclitaxel (P) plus biweekly bevacizumab (B).
    Polyzos, A.
    Kalbakis, K.
    Giassas, S.
    Kalykaki, S.
    Vardakis, N. K.
    Bozionelou, V.
    Saloustros, E. S.
    Kontopodis, E.
    Mavroudis, D.
    Georgoulias, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] IMP321 and weekly paclitaxel as first-line chemoimmunotherapy for metastatic breast cancer (MBC)
    Triebel, F.
    Brignone, C.
    Grygar, C.
    Marcu, M.
    Gutierez, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] IMP321 and Weekly Paclitaxel as First-line Chemoimmunotherapy for Metastatic Breast Cancer (MBC)
    Triebel, Frederic
    Brignone, Chrystelle
    Maya, Gutierrez
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 952 - 953
  • [24] Treatment of metastatic breast cancer with paclitaxel and doxorubicin
    Dombernowsky, P
    Gehl, J
    Boesgaard, M
    Jensen, BW
    Ejlertsen, B
    Jensen, TP
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 13 - 17
  • [25] Paclitaxel and doxorubicin in metastatic breast cancer - Reply
    Gianni, L
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1403 - 1403
  • [26] Weekly Paclitaxel and Pegylated Liposomal Doxorubicin (PEG-LD) as front line therapy in patients with metastatic breast carcinoma
    Palmisano, Valentina
    Leonardi, Vita
    Pepe, Alessio
    Mesi, Lino
    Rondello, Giacomo
    Scianna, Caterina
    Laudani, Agata
    Calabria, Caterina
    Savio, Giuseppina
    Agostara, Biagio
    ANNALS OF ONCOLOGY, 2004, 15 : 44 - 44
  • [27] WEEKLY PACLITAXEL AND PEGYLATED LIPOSOMAL DOXORUBICIN (PEG-LD) AS FRONT LINE THERAPY IN PATIENTS WITH METASTATIC BREAST CARCINOMA
    Palmisano, V.
    Leonardi, V.
    Pepe, A.
    Mesi, L.
    Gugliuzza, M.
    Cianna, C. S.
    Calabria, C.
    Stefano, R.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2004, 15 : 25 - 25
  • [28] Weekly paclitaxel, doxorubicin, and carboplatin in the first-line treatment of patients with metastatic breast cancer
    Hainsworth, JD
    Burris, HA
    Greco, FA
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 13 - 13
  • [29] Phase I trial of pegylated liposomal doxorubicin and lapatinib in the treatment of metastatic breast cancer (MBC): Final results
    Cianfrocca, Mary E.
    Kaklamani, Virginia G.
    Rosen, Steven T.
    Von Roenn, Jamie H.
    Rademaker, Alfred
    Smith, Deborah A.
    Rubin, Stephen D.
    Meservey, Caitlin
    Uthe, Regina
    Gradishar, William John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Prospective evaluation of liposomal doxorubicin (LD) in patients (pts) with metastatic breast cancer (MBC) pretreated with conventional anthracyclines
    Errante, D.
    Bernardi, D.
    Stefani, M.
    Ramello, M.
    Bianco, A.
    Salvagno, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345